Literature DB >> 23680859

[Stress incontinence in elderly women].

H Loertzer1, P Schneider.   

Abstract

Stress incontinence is one of the major challenges in geriatric medicine. This is becoming more apparent in routine urology practice with the demographic changes in the population. A thorough diagnosis for a correct treatment of stress incontinence is as important in elderly women as it is in younger patients. This includes assessing the risk factors of incontinence and obesity, parturition, pelvic surgery and changes in hormone levels are risk factors usually found in elderly women. These are the main reasons why this patient group is most frequently affected. Treatment options do not differ significantly from these of younger women. Lifestyle modification, weight loss and supervised pelvic floor training are the mainstays of conservative therapy and surgical treatment should only be considered after these options have been exhausted. In these cases minimally invasive surgical techniques offer clear advantages especially for elderly often multimorbid women.

Entities:  

Mesh:

Year:  2013        PMID: 23680859     DOI: 10.1007/s00120-013-3167-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  58 in total

1.  Tolerability and efficacy of duloxetine in a nontrial situation.

Authors:  J R A Duckett; M Vella; G Kavalakuntla; M Basu
Journal:  BJOG       Date:  2007-03-13       Impact factor: 6.531

Review 2.  Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

Authors:  L Elaine Waetjen; Peter L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

3.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

4.  Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group.

Authors:  J S Brown; D Grady; J G Ouslander; A R Herzog; R E Varner; S F Posner
Journal:  Obstet Gynecol       Date:  1999-07       Impact factor: 7.661

5.  Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group.

Authors:  J S Brown; E Vittinghoff; J F Wyman; K L Stone; M C Nevitt; K E Ensrud; D Grady
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

6.  [Effect of vaginal estrogen therapy on urinary incontinence in postmenopause].

Authors:  G Schär; O R Köchli; M Fritz; U Haller
Journal:  Zentralbl Gynakol       Date:  1995

7.  An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence.

Authors:  Gunnar Lose; Helle Christina Sørensen; Susanne M Axelsen; Christian Falconer; Kurt Lobodasch; Tosson Safwat
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

8.  The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery.

Authors:  Larry T Sirls; Holly E Richter; Heather J Litman; Kimberly Kenton; Gary E Lemack; Emily S Lukacz; Stephen R Kraus; Howard B Goldman; Alison Weidner; Leslie Rickey; Peggy Norton; Halina M Zyczynski; John W Kusek
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

9.  A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.

Authors:  L Henriksson; M Stjernquist; L Boquist; I Cedergren; I Selinus
Journal:  Am J Obstet Gynecol       Date:  1996-01       Impact factor: 8.661

Review 10.  Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.

Authors:  O Al-Baghdadi; A A A Ewies
Journal:  Climacteric       Date:  2009-04       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.